Talk:Aminolevulinic acid

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Molecular Biology: MCB Low‑importance

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
Low	This article has been rated as Low-importance on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Aminolevulinic acid.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Random COVID thing at the beginning edit

Latest comment: 1 year ago1 comment1 person in discussion

It's sort of vague ("more than a certain amount," "inhibit growth" to what extent?)
It's only mentioned in the lead section and isn't mentioned anywhere else.
It doesn't cite any sources and might be original research (see 4).
There doesn't seem to be additional information anywhere else on the web.

I think it should be removed. BDONGLI (talk) 16:22, 12 August 2022 (UTC)Reply

Proposed Article Merge (of this Aminolevulinic acid with Levulan) edit

Latest comment: 4 years ago5 comments5 people in discussion

Is there any problem merging these two articles together? Chevinki 07:47, 9 March 2007 (UTC)Reply

Yes Searches for levulan — Preceding unsigned comment added by 60.225.81.195 (talk) 10:40, 11 August 2015 (UTC)Reply

No merge edit

No merge is needed as the one article is about a (bio)chemical, the other about the use of the compounds with likewise properties as Aminolevulinic acid. T.vanschaik (talk) 09:43, 23 April 2015 (UTC)Reply

Merge would be bad (as T.vanschaik says) - Since there is no support in 3 or 9 years I'll remove the merge-proposal template(s). - Rod57 (talk) 21:05, 7 July 2016 (UTC)Reply

Despite having this discussion, in 2017 someone modified the Levulan to be a redirector to the Aminolevulinic acid page without integrating any of the Levulan page content into the Aminolevulinic acid page. I just undid that modification. Phedrence (talk) 11:33, 12 February 2020 (UTC)Reply

Add topic